Suppr超能文献

硝酸铅诱导大鼠高胆固醇血症的发生:胆固醇稳态相关肝酶的非甾醇依赖性基因调控

Lead nitrate-induced development of hypercholesterolemia in rats: sterol-independent gene regulation of hepatic enzymes responsible for cholesterol homeostasis.

作者信息

Kojima Misaki, Masui Toshimitsu, Nemoto Kiyomitsu, Degawa Masakuni

机构信息

Laboratory of Animal Gene Function, Department of Physiology and Gene Regulation, National Institute of Agrobiological Sciences, Kannondai 2-1-2, Tsukuba 305-8602, Japan.

出版信息

Toxicol Lett. 2004 Dec 1;154(1-2):35-44. doi: 10.1016/j.toxlet.2004.06.010.

Abstract

Changes in the gene expressions of hepatic enzymes responsible for cholesterol homeostasis were examined during the process of lead nitrate (LN)-induced development of hypercholesterolemia in male rats. Total cholesterol levels in the liver and serum were significantly increased at 3-72 h and 12-72 h, respectively, after LN-treatment (100 micromol/kg, i.v.). Despite the development of hypercholesterolemia, the genes for hepatic 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) and other enzymes (FPPS, farnesyl diphosphate synthase; SQS, squalene synthase; CYP51, lanosterol 14alpha-demethylase) responsible for cholesterol biosynthesis were activated at 3-24 h and 12-18 h, respectively. On the other hand, the gene expression of cholesterol 7alpha-hydroxylase (CYP7A1), a catabolic enzyme of cholesterol, was remarkably suppressed at 3-72 h. The gene expression levels of cytokines interleukin-1beta (IL-1beta) and TNF-alpha, which activate the HMGR gene and suppress the CYP7A1 gene, were significantly increased at 1-3 h and 3-24 h, respectively. Furthermore, gene activation of SREBP-2, a gene activator of several cholesterogenic enzymes, occurred before the gene activations of FPPS, SQS and CYP51. This is the first report demonstrating sterol-independent gene regulation of hepatic enzymes responsible for cholesterol homeostasis in LN-treated male rats. The mechanisms for the altered-gene expressions of hepatic enzymes in LN-treated rats are discussed.

摘要

在硝酸铅(LN)诱导雄性大鼠高胆固醇血症的过程中,研究了负责胆固醇稳态的肝酶基因表达的变化。静脉注射LN(100微摩尔/千克)后,肝脏和血清中的总胆固醇水平分别在3至72小时和12至72小时显著升高。尽管出现了高胆固醇血症,但负责胆固醇生物合成的肝3-羟基-3-甲基戊二酰辅酶A还原酶(HMGR)和其他酶(法尼基二磷酸合酶(FPPS)、角鲨烯合酶(SQS)、羊毛甾醇14α-脱甲基酶(CYP51))的基因分别在3至24小时和12至18小时被激活。另一方面,胆固醇分解代谢酶胆固醇7α-羟化酶(CYP7A1)的基因表达在3至72小时受到显著抑制。激活HMGR基因并抑制CYP7A1基因的细胞因子白细胞介素-1β(IL-1β)和肿瘤坏死因子-α(TNF-α)的基因表达水平分别在1至3小时和3至24小时显著升高。此外,几种胆固醇生成酶的基因激活剂SREBP-2的基因激活发生在FPPS、SQS和CYP51的基因激活之前。这是第一份证明在LN处理的雄性大鼠中负责胆固醇稳态的肝酶存在不依赖固醇的基因调控的报告。讨论了LN处理大鼠肝酶基因表达改变的机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验